Maximum quantity allowed is 999
请选择数量
CAS RN: 5728-52-9 | 产品编码: B1278
4-Biphenylacetic Acid

技术规格
Appearance | White to Orange to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 161.0 to 165.0 °C |
NMR | confirm to structure |
物性(参考值)
熔点 | 163 °C |
GHS
象形图 |
![]() |
信号词 | Danger |
危险性说明 | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相关法规
RTECS# | DU8229050 |
运输信息
UN编号 | UN2811 |
类别 | 6.1 |
包装类别 | III |
HS编码* | 2916.39-000 |
应用
Felbinac: A Non-Selective Cyclooxygenase (COX) Inhibitor
Felbinac is a nonsteroidal and non-selective cyclooxygenase (COX) inhibitor which has anti-inflammatory effects. The mechanism of action is mainly by inhibition of the enzyme COX in the arachidonic acid metabolism pathway, resulting in reduced prostaglandin synthesis. (The product is for research purpose only.)
References
- Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents
- The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents
- Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma by high-performance liquid chromatography
- Fluorous derivatization and fluorous-phase separation for fluorometric determination of naproxen and felbinac in human plasma
参考文献
文档
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。